THE battle is on to give people two coronavirus jabs after scientists revealed last night that a double dose is highly effective against the new mutant Indian strain.
Two doses of Pfizer or AstraZeneca deliver only slightly less protection than against the dominant Kent strain.
Public Health England revealed the good news as soldiers from the Royal Horse Artillery joined the fight against the Indian variant.
They went door to door with leaflets to encourage Covid vaccination uptake in the virus hot spot of Halliwell in Bolton, Lancs.
According to PHE, the Pfizer vaccine is 88% effective against symptoms of the variant after a second shot, compared with 93% against the Kent strain.
The research – which came as England yesterday passed 50 million vaccinations – was heralded as groundbreaking by Health Secretary Matt Hancock.
The number of Brits who have had their first jab is nearly 38 million while 22.07 million have had two.
Mr Hancock said: “We can now be confident that over 20 million people – more than one in three – have significant protection against this new variant, and that number is growing by the hundreds of thousands every single day.”
But scientists last night sounded a note of caution as it emerged both vaccines are just 33% effective against symptoms of the Indian variant after one dose.
One shot of either vaccine delivers 51% protection against the Kent variant after three weeks.
Scientists called on ministers to speed up the jabs roll-out to get doses dished out as fast as possible.
Currently, the last remaining lockdown restrictions, including social distancing and masks, are set to be scrapped on June 21.
Continue reading your story on the app
Continue reading your story in the newspaper
‘£500K A DAY' FOR PPE STUCK IN CHINA
AROUND £500,000 of taxpayer cash is being spent on storage space in China every day.
Kane's got eye on trophy life
NEVER TRY TELLING SILVERWARE-STARVED HARRY THE OLD CUP’S LOST HER LOOKS...
I WANT TO MAKE CAROLINE PROUD
OLLY ON RETURN AS HOST
Hero driver to meet family of mum he tried to save
Man tells how he ran over knife killer
AN ACT OF GORD!
Conflated answers Elliott’s prayers
Pandemic dogs crisis
ANIMAL charities are at breaking point as people dump puppies they got during the pandemic.
The hippo drone
HIP, hip hooray! These stunning aerial wildlife pics wowed the judges in a drone photo competition.
Hidden death toll of Afghan invasion
2,000 veteran suicides since 2001... 6 since fall of Kabul
‘US killed aid family'
A US drone strike targeting an ISIS suicide bomber in Kabul killed an innocent aid worker and his seven children, a report claims.
Bojo boat's ‘UK snub'
BORIS Johnson’s national flagship to showcase “the best of British” could be designed by foreigners.
Follow Your Nose
MEISSA VACCINES says a nasal spray is the best way to stop transmission of the coronavirus just breathe in | Could a nasal spray vaccine help end the pandemic?
The Promise Of Paxlovid
If Pfizer’s Covid-19 treatment is to help end the pandemic, more nations need rapid access
Will This Covid Star Get a Second Act?
Vir scored with monoclonal antibodies in the pandemic’s early days. Now it needs more
Time for a Boost
As changes to the vaccine policy are announced we unpack what you need to know
MOST EFFECTIVE COVID VACCINES
CDC says mRNA works – China’s jabs are JUNK!
Merck's Fumble Gives Pfizer a Win
It shelved a 10-year-old drug that’s provided a key component in a rival’s $17 billion Covid pill
MIRACLE COVID DRUG COMES WITH A CATCH!
A BREAKTHROUGH medication has been approved by the FDA to fight COVID-19, but it can cause potentially life-threatening interactions with a variety of widely prescribed drugs, warned experts.
Vacuna COVID-19 en niños: soluciona tus dudas
Los pequeños de 5 a 11 años ya pueden vacunarse frente al coronavirus. De la mano de dos expertos en Pediatría, resolvemos algunas cuestiones que preocupan a los padres.
The Swiss Army Vaccine
There are promising signs that a single vaccine could protect against multiple coronaviruses and variants. But with pharma companies invested in boosters, will anyone pay to develop it?
Covid Pills Face a Truth Problem
Merck’s new medicine is set to enter a landscape where misinformation is widespread